• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数和良性前列腺增生对中老年男性骨骼健康的影响。

The Impact of Body Mass Index and Benign Prostatic Hyperplasia on Bone Health of Middle-Aged and Older Men.

作者信息

Chuang Tzyy-Ling, Chen Pao-Liang, Koo Malcolm, Chuang Mei-Hua, Wang Yuh-Feng

机构信息

Department of Nuclear Medicine Dalin Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation Chiayi Taiwan.

School of Medicine Tzu Chi University Hualien Taiwan.

出版信息

Obes Sci Pract. 2025 Jan 8;11(1):e70037. doi: 10.1002/osp4.70037. eCollection 2025 Feb.

DOI:10.1002/osp4.70037
PMID:39781546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707624/
Abstract

OBJECTIVE

Osteoporosis significantly affects older adults by reducing bone mass and increasing fracture risk, thereby impacting morbidity and mortality. This study aimed to investigate the relationship between bone mineral density (BMD), body mass index (BMI), and trabecular bone score (TBS) among middle-aged and older men with or without benign prostatic hyperplasia (BPH).

METHODS

A retrospective study was conducted using health examination data from male participants aged 50-98 years collected at a regional hospital in southern Taiwan. Simple and multiple linear regression analyses were employed to examine the relationships between TBS and the independent variables. A total of 3714 middle-aged and older men were included in the analysis.

RESULTS

Findings indicated that higher BMI was associated with greater BMD; however, the relationship with TBS suggested potential bone quality degradation in cases of underweight and obesity. Multiple linear regression analysis demonstrated that age, waist circumference, BMD, underweight status, and obesity were significantly associated with TBS.

CONCLUSION

This study revealed the associative relationship between BMI and bone health: higher BMI was associated with increased bone density but also related to a decline in bone quality as measured by TBS, particularly in cases of obesity. These results emphasized the importance of managing BMI to optimize both bone density and quality, especially in middle-aged and older men with or at risk of BPH.

摘要

目的

骨质疏松症通过降低骨量和增加骨折风险,对老年人产生显著影响,进而影响发病率和死亡率。本研究旨在调查患有或未患有良性前列腺增生(BPH)的中老年男性的骨矿物质密度(BMD)、体重指数(BMI)和小梁骨评分(TBS)之间的关系。

方法

利用台湾南部一家地区医院收集的50 - 98岁男性参与者的健康检查数据进行回顾性研究。采用简单和多元线性回归分析来检验TBS与自变量之间的关系。共有3714名中老年男性纳入分析。

结果

研究结果表明,较高的BMI与较高的BMD相关;然而,与TBS的关系表明,体重过轻和肥胖情况下可能存在骨质退化。多元线性回归分析表明,年龄、腰围、BMD、体重过轻状态和肥胖与TBS显著相关。

结论

本研究揭示了BMI与骨骼健康之间的关联关系:较高的BMI与骨密度增加相关,但也与TBS所衡量的骨质下降有关,尤其是在肥胖情况下。这些结果强调了控制BMI以优化骨密度和骨质的重要性,特别是对于患有或有BPH风险的中老年男性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d80e/11707624/7716d09dbd22/OSP4-11-e70037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d80e/11707624/eda95e6ad84c/OSP4-11-e70037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d80e/11707624/c2ee6e8b94a8/OSP4-11-e70037-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d80e/11707624/7716d09dbd22/OSP4-11-e70037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d80e/11707624/eda95e6ad84c/OSP4-11-e70037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d80e/11707624/c2ee6e8b94a8/OSP4-11-e70037-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d80e/11707624/7716d09dbd22/OSP4-11-e70037-g001.jpg

相似文献

1
The Impact of Body Mass Index and Benign Prostatic Hyperplasia on Bone Health of Middle-Aged and Older Men.体重指数和良性前列腺增生对中老年男性骨骼健康的影响。
Obes Sci Pract. 2025 Jan 8;11(1):e70037. doi: 10.1002/osp4.70037. eCollection 2025 Feb.
2
The Association Between Trabecular Bone Score and Lumbar Spine Volumetric BMD Is Attenuated Among Older Men With High Body Mass Index.在体重指数较高的老年男性中,小梁骨评分与腰椎体积骨密度之间的关联减弱。
J Bone Miner Res. 2016 Oct;31(10):1820-1826. doi: 10.1002/jbmr.2867. Epub 2016 May 27.
3
A Comparison of Bone Mineral Density and Its Predictors in HIV-Infected and HIV-Uninfected Older Men.HIV 感染和未感染老年男性的骨密度及其预测因素比较。
Endocr Pract. 2021 Dec;27(12):1225-1231. doi: 10.1016/j.eprac.2021.07.015. Epub 2021 Jul 31.
4
Association of Trabecular Bone Score (TBS) With Incident Clinical and Radiographic Vertebral Fractures Adjusted for Lumbar Spine BMD in Older Men: A Prospective Cohort Study.老年男性小梁骨评分(TBS)与经腰椎骨密度调整的临床和影像学椎体骨折发生率的关联:一项前瞻性队列研究。
J Bone Miner Res. 2017 Jul;32(7):1554-1558. doi: 10.1002/jbmr.3130. Epub 2017 Apr 7.
5
Older Age and Higher Body Mass Index Are Associated With a More Degraded Trabecular Bone Score Compared to Bone Mineral Density.与骨密度相比,年龄较大和较高的身体质量指数与更差的小梁骨评分相关。
J Clin Densitom. 2019 Apr-Jun;22(2):266-271. doi: 10.1016/j.jocd.2017.06.006. Epub 2017 Jul 13.
6
Fat Mass Does Not Increase the Precision Error of Trabecular Bone Score Measurements.脂肪量不会增加骨小梁评分测量的精密度误差。
J Clin Densitom. 2019 Jul-Sep;22(3):359-366. doi: 10.1016/j.jocd.2019.01.001. Epub 2019 Jan 5.
7
Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.老年男性骨小梁骨密度评分(TBS)变化的预测因素:来自男性骨质疏松性骨折(MrOS)研究的结果。
Osteoporos Int. 2018 Jan;29(1):49-59. doi: 10.1007/s00198-017-4273-z. Epub 2017 Oct 31.
8
Densitometer-Specific Differences in the Correlation Between Body Mass Index and Lumbar Spine Trabecular Bone Score.骨密度仪在体重指数与腰椎小梁骨评分相关性方面的特定差异
J Clin Densitom. 2017 Apr-Jun;20(2):233-238. doi: 10.1016/j.jocd.2016.11.003. Epub 2016 Dec 26.
9
Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.男性慢性阻塞性肺疾病患者骨密度和小梁骨评分与椎体骨折的独立相关性。
Osteoporos Int. 2018 Mar;29(3):615-623. doi: 10.1007/s00198-017-4314-7. Epub 2017 Nov 22.
10
Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density.2型糖尿病且骨密度正常的绝经后女性中与小梁骨评分相关的因素。
World J Diabetes. 2022 Jul 15;13(7):553-565. doi: 10.4239/wjd.v13.i7.553.

本文引用的文献

1
Medical management of benign prostatic hyperplasia.良性前列腺增生的医学管理。
Cleve Clin J Med. 2024 Mar 1;91(3):163-170. doi: 10.3949/ccjm.91a.23027.
2
Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines.骨质疏松症的诊断和管理:指南的综合综述。
Obstet Gynecol Surv. 2023 Nov;78(11):657-681. doi: 10.1097/OGX.0000000000001181.
3
A Review of Various Clinical Practice Guidelines on Osteoporosis in the Last 5 Years.过去5年骨质疏松症的各种临床实践指南综述
Indian J Orthop. 2023 Nov 20;57(Suppl 1):7-24. doi: 10.1007/s43465-023-01031-0. eCollection 2023 Dec.
4
Trabecular Bone Score as a Marker of Skeletal Fragility Across the Spectrum of Chronic Kidney Disease: A Systematic Review and Meta-analysis.骨小梁评分作为慢性肾脏病谱中骨骼脆弱性的标志物:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2024 Jun 17;109(7):e1534-e1543. doi: 10.1210/clinem/dgad724.
5
Causal Associations Between Lifestyle Habits and Risk of Benign Prostatic Hyperplasia: A Two-Sample Mendelian Randomization Study.生活方式习惯与良性前列腺增生风险之间的因果关系:两样本孟德尔随机化研究。
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad187.
6
The Impact of Metabolic Syndrome on Bone Mass in Men: Systematic Review and Meta-Analysis.代谢综合征对男性骨量的影响:系统评价与荟萃分析
Biomedicines. 2023 Jul 6;11(7):1915. doi: 10.3390/biomedicines11071915.
7
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging.有关在骨质疏松症管理中使用小梁骨评分 (TBS) 的临床应用的最新情况:欧洲临床和经济骨质疏松症、骨关节炎和肌肉骨骼疾病学会 (ESCEO) 与国际骨质疏松基金会 (IOF) 在世界卫生组织协作中心的主持下举办的专家组会议的结果,该中心负责骨骼肌肉健康和老龄化的流行病学。
Osteoporos Int. 2023 Sep;34(9):1501-1529. doi: 10.1007/s00198-023-06817-4. Epub 2023 Jul 1.
8
Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review.老年有跌倒风险的良性前列腺增生患者抗毒蕈碱药物和α受体阻滞剂的应用管理:临床评价。
Eur Geriatr Med. 2023 Aug;14(4):733-746. doi: 10.1007/s41999-023-00798-7. Epub 2023 May 28.
9
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments.衰老和与衰老相关的疾病:从分子机制到干预和治疗。
Signal Transduct Target Ther. 2022 Dec 16;7(1):391. doi: 10.1038/s41392-022-01251-0.
10
Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules.磷酸二酯酶抑制剂的最新进展:临床试验、新出现的适应症和新型分子。
Front Pharmacol. 2022 Nov 24;13:1057083. doi: 10.3389/fphar.2022.1057083. eCollection 2022.